Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2023 Earnings Call Transcript August 8, 2023
Revance Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.8 EPS, expectations were $0.72.
Operator: Welcome to the Revance Therapeutics Second Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this call is being recorded today, Tuesday, August 8, 2023. I would now...
